Aralez Pharmaceuticals Inc. (ARLZ)
(Real Time Quote from BATS)
$0.03 USD
-0.01 (-19.58%)
Updated Aug 20, 2018 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ARLZ]
Reports for Purchase
Showing records 1 - 20 ( 38 total )
Industry: Medical - Drugs
Terminating Coverage
Provider: H.C. Wainwright & Co., Inc.
Industry: Medical - Drugs
Aralez States Intent to Exit U.S. Pharma Business; Placing Rating Under Review
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
4Q and FY2017 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
Industry: Medical - Drugs
Riding the Aralez Express; Initiating at Buy and $6 Price Target
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Industry: Medical - Drugs
2018 Top Ideas; Healthcare Sector Review/Preview
Provider: Bloom Burton & Company
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
SMALL-CAP SQUAWK
Provider: JGR Capital Partners
Industry: Medical - Drugs
3Q-2017 Preview
Provider: Bloom Burton & Company
Industry: Medical - Drugs
COMPASS Likely to Impact Zontivity Path to Success.
Provider: Bloom Burton & Company
Analyst: MARTIN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
2Q-2017 Preview
Provider: Bloom Burton & Company
Industry: Medical - Drugs
Weekly U.S. prescription data for key products sold by companies in our coverage universe
Provider: Bloom Burton & Company